Skip to main content
. 2015 Jul 27;65(637):e530–e537. doi: 10.3399/bjgp15X686101

Table 2.

Primary outcomes: daily knee pain severity measured with a diary and knee pain and function measured with the Knee Injury and Osteoarthritis Outcome Score

Paracetamol (n= 52) Mean (SD) Diclofenac (n= 52) Mean (SD) Mean differencesa (95% CI) Effect size
Course of daily knee pain during:
  2 weeks 3.5 (2.1) 3.0 (2.1) 0.5 (−0.2 to 1.3) 0.35
  4 weeks 3.3 (2.1) 3.5 (2.1) −0.2 (−1.0 to 0.7) −0.03

KOOS painb
  3 weeks 38.3 (19.5) 39.6 (20.7) −1.6 (−9.5 to 6.3) 0.04
  6 weeks 35.0 (19.4) 40.2 (22.1) −5.6 (−13.7 to 2.5) −0.16
  9 weeks 34.8 (18.8) 38.5 (20.7) −3.5 (−11.3 to 4.4) −0.03
  12 weeks 34.8 (19.4) 37.4 (21.0) −2.8 (−10.7 to 5.1) 0.01

KOOS functionb
  3 weeks 33.9 (19.3) 34.2 (21.7) −0.6 (−8.7 to 7.6) 0.07
  6 weeks 31.9 (19.9) 33.1 (20.6) −1.8 (−9.7 to 6.2) 0.04
  9 weeks 28.3 (19.7) 33.1 (20.3) −4.6 (−12.6 to 3.3) −0.10
  12 weeks 28.4 (19.5) 31.4 (20.2) −2.7 (−10.6 to 5.0) −0.02
a

Results of the generalised estimating equations analyses.

b

A higher score is more pain/worse function.

KOOS= Knee Injury and Osteoarthritis Outcome Score.